Transgene Biotek Quarterly Results for Trading Insights
In Mar 2026, Transgene Biotek (TRABI) reported revenue ₹0 Cr and net profit ₹-1 Cr. Browse Transgene Biotek financial data for revenue, profit, balance sheet and cash flow data.
TRABI Quarterly Results — Revenue, Profit & EPS Highlights
Transgene Biotek latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore TRABI price trends to track price trends across different timeframes.
- Net Profit of ₹-1 Cr in Mar 2026 (+0.0% vs Mar 2025)
- Operating Margin of -560.0% in Mar 2026 (-400.0pp vs Sept 2025)
- Earnings Per Share of ₹-0.06 in Mar 2026 (-20.0% vs Sept 2025)
Transgene Biotek Quarterly Results — Revenue, EBITDA, Net Profit & EPS
TRABI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 0 | 0 | 0 | 0 | - | - |
| Net Profit (₹ Cr) | -1 | 0 | -1 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 0 | 0 | -1 | 0 | 0 | - | - |
| EPS (₹) | -0.06 | -0.05 | -0.09 | -0.06 | -0.05 | - | - |
| Operating Margin (%) | -560.0% | -160.0% | -675.0% | -280.0% | -120.0% | - | - |
TRABI Share Price Trend — 1-Year Movement Across Quarterly Results
Transgene Biotek 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit TRABI share price.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
TRABI vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Transgene Biotek latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹126,904.34 Cr | 8905.0 | 6,660 | 551 | +4.6% | +17.6% | 8.3% | 241.9 |
|
Max Healthcare Inst…
Mar 2026 |
₹106,365.81 Cr | 1102.4 | 2,191 | 342 | +1.1% | +12.0% | 15.6% | 313.2 |
|
Fortis Healthcare
Mar 2026 |
₹72,740.22 Cr | 951.2 | 2,375 | 271 | -0.3% | +16.9% | 11.4% | 270.2 |
|
Aster DM Healthcare
Mar 2026 |
₹42,133.60 Cr | 815.2 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 299.7 |
|
Narayana Hrudayalaya
Mar 2026 |
₹40,825.16 Cr | 2025.9 | 2,623 | 224 | +57.3% | +74.5% | 8.5% | 183.8 |
All amounts in ₹ Crores